Development and external validation of a machine learning prediction…
A quick blood test can now reliably distinguish a life-threatening immune condition from routine mono in children, enabling urgent treatment when it matters most.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Changes in DNA methylation-based aging predicts brain damage and…
Signs of accelerated aging in DNA predict brain shrinkage and dementia risk, offering a measurable target for intervention studies in midlife.
Promising but preliminaryComparative cardiovascular efficacy of antidiabetic therapies in type…
Two common diabetes drugs tackle different heart problems: GLP-1 drugs prevent strokes and early death, while SGLT2 drugs prevent heart failure—knowing which does what helps doctors pick the right one.
Novel or significantly improved treatmentVibecotamab for measurable residual disease in acute myeloid leukemia…
A new antibody therapy clears pre-leukemia in some blood cancer patients while causing mostly mild side effects, expanding treatment options beyond chemotherapy.
Promising but preliminaryBeyond vasodilation
A non-vasodilator drug improved breathing, exercise capacity, and heart health in pulmonary hypertension patients without worsening other heart problems—a genuinely new approach.